Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Accenture
Federal Trade Commission
UBS
Colorcon
McKesson
QuintilesIMS
McKinsey
Mallinckrodt

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011909

« Back to Dashboard
NDA 011909 describes NARDIL, which is a drug marketed by Parke Davis and is included in one NDA. It is available from two suppliers. Additional details are available on the NARDIL profile page.

The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.

Summary for NDA: 011909

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 011909

Mechanism of ActionMonoamine Oxidase Inhibitors

Suppliers and Packaging for NDA: 011909

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NARDIL
phenelzine sulfate
TABLET;ORAL 011909 NDA Parke-Davis Div of Pfizer Inc 0071-0350 0071-0350-60 60 TABLET, FILM COATED in 1 BOTTLE (0071-0350-60)
NARDIL
phenelzine sulfate
TABLET;ORAL 011909 NDA Greenstone LLC 59762-0119 59762-0119-1 60 TABLET, FILM COATED in 1 BOTTLE (59762-0119-1)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
US Department of Justice
Mallinckrodt
Citi
Fuji
Johnson and Johnson
Argus Health
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot